Amundi - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.

Quarter-by-quarter ownership
Amundi ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$44,879,609
+6.5%
1,612,055
+17.5%
0.02%
+4.8%
Q2 2023$42,143,948
+12.5%
1,372,320
+32.9%
0.02%
+5.0%
Q1 2023$37,455,486
+11.1%
1,032,685
+4.3%
0.02%
+11.1%
Q4 2022$33,725,043
-2.6%
990,276
+19.4%
0.02%
-14.3%
Q3 2022$34,620,000
-14.4%
829,606
-11.4%
0.02%
-34.4%
Q2 2022$40,441,000
+230.2%
936,566
+212.2%
0.03%
+300.0%
Q1 2022$12,248,000
+52.6%
299,977
+50.2%
0.01%
+60.0%
Q4 2021$8,025,000
-84.1%
199,723
-85.7%
0.01%
-85.7%
Q3 2021$50,353,000
-56.6%
1,393,281
-50.7%
0.04%
-56.8%
Q2 2021$115,929,0002,828,2650.08%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$122,204,89747.65%
Vantage Consulting Group Inc 1,022,194$36,829,65020.91%
Indie Asset Partners, LLC 433,000$15,600,99018.22%
Overbrook Management Corp 578,783$20,853,5515.46%
Silicon Valley Community Foundation 1,032,320$37,194,4905.36%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,047,049$109,785,1754.64%
Geo Capital Gestora de Recursos Ltd 142,748$5,1433.81%
Renaissance Capital LLC 123,913$4,464,5853.31%
Rokos Capital Management LLP 1,106,813$40,077,6982.96%
Lagoda Investment Management, L.P. 101,500$3,657,0452.60%
View complete list of ROYALTY PHARMA PLC shareholders